§8732. Drug price notifications and disclosures
1. Notifications by manufacturers. No later than January 30, 2020 and annually thereafter, a manufacturer shall notify the organization when the manufacturer has during the prior calendar year:
A. Increased the wholesale acquisition cost of a brand-name drug by more than 20% per pricing unit; [PL 2019, c. 470, §8 (NEW).]
B. Increased the wholesale acquisition cost of a generic drug that costs at least $10 per pricing unit by more than 20% per pricing unit; or [PL 2019, c. 470, §8 (NEW).]
C. Introduced a new drug for distribution in this State when the wholesale acquisition cost is greater than the amount that would cause the drug to be considered a specialty drug under the Medicare Part D program. For the purposes of this subsection, "Medicare Part D" has the same meaning as in section 254‑D, subsection 1, paragraph F. [PL 2019, c. 470, §8 (NEW).]
[PL 2019, c. 470, §8 (NEW).]
2. Disclosures by manufacturers, wholesale drug distributors and pharmacy benefits managers. Within 60 days of a request from the organization relating to a specific prescription drug, a manufacturer, wholesale drug distributor or pharmacy benefits manager shall notify the organization of pricing component data per pricing unit of a drug.
[PL 2019, c. 470, §8 (NEW).]
SECTION HISTORY
PL 2019, c. 470, §8 (NEW).